RP
ALNY icon

Regeneron Pharmaceuticals’s Alnylam Pharmaceuticals ALNY Stock Holding History

Regeneron Pharmaceuticals’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$1.45B Hold
4,444,445
– – 97.6% 1
2025
Q1 		$1.2B Hold
4,444,445
– – 97.23% 1
2024
Q4 		$1.05B Buy
+4,444,445
New +$1.05B 95.54% 1